May 23, 2011 — Use of short- and long-acting inhaled anticholinergic medications (IACs) is associated with an increased risk for acute urinary retention (AUR) in men with chronic obstructive pulmonary ...

The use of inhaled anticholinergic agents (medications that help reduce bronchospasm) by patients with chronic obstructive pulmonary disease (COPD) is associated with a significantly increased risk of ...

Treatment is therefore directed toward relief of symptoms and a reduction in the incidence of acute exacerbations. Within the past decade, major advances in management have been made in the ...

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., April 28, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro™ Ellipta ...

Angiogram of an MI (left) and a normal coronary artery (right) Inhaled anticholinergic agents, the most common treatment for chronic obstructive pulmonary disease (COPD), may increase the risk of ...

Chronic respiratory failure is associated with earlier and greater risks of cardiovascular diseases among individuals with COPD.

WINSTON-SALEM, N.C. – New research out of Wake Forest University School of Medicine shows that use of the most commonly prescribed once-a-day treatment for chronic obstructive pulmonary disease (COPD) ...

Arnuity™ Ellipta® now available in the US for once-daily treatment of asthma. Incruse® Ellipta® now available in the US for once-daily treatment for COPD. Arnuity ™ Ellipta (fluticasone furoate ...

DEAR DR. ROACH: I am a 73-year-old male with chronic obstructive pulmonary disease (COPD). I pretty much have it under control with medication, but I am still not able to do a whole lot, as I feel ...

Dear Dr. Roach: I am a 73-year-old male with chronic obstructive pulmonary disease (COPD). I pretty much have it under control with medication, but I am still not able to do a whole lot, as I feel ...